Robert Stagg

This profile gathers the share dealings of Robert Stagg in OncoMed Pharmaceuticals Inc. Over a trading history stretching from 24 April 2018 to 23 April 2019, the count stands at 4 filings.

On the market, this insider has only sold: 3 sales, €14k in total.

The latest filing, published on 23 April 2019, reports a transaction in OncoMed Pharmaceuticals Inc. Typically, a trade is published a median of 1 day after it takes place. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.